Webinars
White Paper & On-demand Webinar:
This report, the seventh in our Trinity Drug Index series, outlines key themes and emerging trends in the industry as we progress towards a new world of targeted and innovative products. We provide a comprehensive evaluation of the performance of novel drugs approved by the FDA in 2021, scoring each on its commercial performance, therapeutic value and R&D investment.
2021 saw 40 unique drug and biologic approvals, of which ~33% (13/40) were Oncology, followed by…
Read Now
Webinars
Available On Demand
The addition of real-world data (RWD) to other data streams through technology allows the patient impact to be magnified many times. Combined with PMR, RWD can drive exceptional insights and accuracy in demand assessments, segmentation, message testing, market mapping and ATUs. Amplified with GenAI and solutions like Real Insights and RealWorldEDGE, the range of RWD-powered use cases broadens even further.
Join Rajeev Rangachari, CTO of Trinity Life Sciences, as he hosts a wide-ranging discussion on enabling exponential outcomes with RWD…
Watch Now
Blog
Published February 27, 2025
We’re delighted to bring an external expert perspective to the “One Chapter Ahead” blog series and the important topic of culture and collaboration. Amy Saunders is a recognized customer experience global leader across life science verticals including pharma, med devices and consumer packaged goods (CPG) for companies such as J&J Consumer, W.L. Gore and Novartis. Most recently, Amy established and led the Customer Experience function at Novartis International which encompassed customer experience (Cx) strategy, engagement planning and production, patient support…
Read Now
Webinars
Available On Demand
Join Trinity Life Sciences for a virtual demo where value, access and pricing experts Max Hunt and Andreia Ribeiro will demonstrate Trinity HTA Vision, our cloud-based dashboard with GenAI capabilities.It is not enough to know what the health technology assessment (HTA) decisions are and when they are made—with the landscape continually evolving, analogues and future impact cannot be judged by looking at decisions alone. Nuanced implications come from expert knowledge of countries/agencies, therapeutic areas and lifecycle stage.Discover the power of HTA…
Watch Now
Webinars
Available On Demand
Are you ready to take a bite out of IC administration complexity?
Nothing demotivates a sales team like delayed or inaccurate incentive compensation (IC) calculations and payouts. While administering an IC plan may seem simple to outsiders, seasoned IC administrators know that’s not the case. It takes laser-focused attention to detail and timeliness to manage the constant flow of updates and ensure everything runs smoothly.
Join Trinity Life Sciences for a virtual lunch and learn where IC experts, Miles Scotcher…
Watch Now
Blog
Published February 5, 2025
How can pharma brands connect digital marketing experiences to achieve truly transformational customer engagement?
Brands that are leading the way demonstrate a complete grasp of fundamental digital marketing concepts and drive innovation in the ways that they engage customers. These brands maintain consistency in their message and interactions but tailor them to customer specific needs—and the innovation differentiates them in a market where many brands follow similar go-to-market strategies.
By exploring new ways of engagement in existing channels, they create…
Read Now
Webinars
Available On Demand
There is no room for missteps along the journey to evaluate the viability of assets in early stages of development. When making go/no go decisions, many critical questions must be answered across the early asset lifecycle.Join a team of cross-functional experts from Trinity Life Sciences for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives. The team will share real-life examples highlighting what life sciences companies need to be thinking about and common…
Watch Now
Blog
Published January 28, 2025
Health equity continues to be a hot topic in the life sciences industry. ISPOR EU sessions addressed several key questions surrounding the impact of health equity on HTA decision-making, the methodologies that should be employed, and the opportunities and challenges of incorporating health equity into health technology assessment (HTA).
Ahead of ISPOR EU, Trinity’s HTA Vision team analyzed the impact of health equity on HTA agency behavior across six recent pharmaceutical launches and seven countries: Australia, Canada, England, France, Germany,…
Read Now
Blog
Published January 24, 2025
On January 20, 2025, CMS announced the set of fifteen drugs targeted for the second round of Maximum Fair Price (MFP) “negotiations” under IRA. With the outcomes of the first price “negotiations” announced only last August, the IRA MFP process is still in its early development and there remains uncertainty over how it will evolve – particularly in terms of the extent to which CMS will aim for true drug cost reductions vs. generating political capital via nominal “savings” on…
Read Now
Blog
Published January 21, 2025
Trinity recently presented a poster on climate resilience and environmental sustainability at ISPOR EU, titled “Attitudes and Perceptions on Environmental Sustainability Efforts in the Life Sciences Industry: A Cross-Sectional Survey from HEOR and Industry Professionals.” The poster discussed results from a recent survey conducted by our CREST (Climate Resilience and Environmental Sustainability at Trinity) team, which identified perceptions regarding life sciences industry efforts to tackle sustainability, particularly within HEOR, evidence generation and value communication strategy. We also published our new…
Read Now
